These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26912152)

  • 1. Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk.
    Jin L; Lin Z; Xu A
    Diabetes Metab J; 2016 Feb; 40(1):22-31. PubMed ID: 26912152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
    Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
    Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
    Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
    Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FGF21-adiponectin axis in controlling energy and vascular homeostasis.
    Hui X; Feng T; Liu Q; Gao Y; Xu A
    J Mol Cell Biol; 2016 Apr; 8(2):110-9. PubMed ID: 26993043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.
    Berti L; Irmler M; Zdichavsky M; Meile T; Böhm A; Stefan N; Fritsche A; Beckers J; Königsrainer A; Häring HU; de Angelis MH; Staiger H
    Mol Metab; 2015 Jul; 4(7):519-27. PubMed ID: 26137439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The moderate essential amino acid restriction entailed by low-protein vegan diets may promote vascular health by stimulating FGF21 secretion.
    McCarty MF
    Horm Mol Biol Clin Investig; 2016 Feb; 30(1):. PubMed ID: 26872317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases.
    Cheung BM; Deng HB
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):659-66. PubMed ID: 24697521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of fibroblast growth factor 21 in atherosclerosis.
    Kokkinos J; Tang S; Rye KA; Ong KL
    Atherosclerosis; 2017 Feb; 257():259-265. PubMed ID: 28012645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
    Woo YC; Xu A; Wang Y; Lam KS
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
    Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
    Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses.
    Salminen A; Kaarniranta K; Kauppinen A
    Ageing Res Rev; 2017 Aug; 37():79-93. PubMed ID: 28552719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies.
    Antonellis PJ; Kharitonenkov A; Adams AC
    J Anim Sci; 2014 Feb; 92(2):407-13. PubMed ID: 24398833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases.
    Itoh N
    Front Endocrinol (Lausanne); 2014; 5():107. PubMed ID: 25071723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of FGF21 in atherosclerosis pathogenesis.
    Tabari FS; Karimian A; Parsian H; Rameshknia V; Mahmoodpour A; Majidinia M; Maniati M; Yousefi B
    Rev Endocr Metab Disord; 2019 Mar; 20(1):103-114. PubMed ID: 30879171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.
    Ye D; Wang Y; Li H; Jia W; Man K; Lo CM; Wang Y; Lam KS; Xu A
    Hepatology; 2014 Sep; 60(3):977-89. PubMed ID: 24590984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.